Bayer is nearing the end of the road for glyphosate, executives say

Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.

Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.

More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.

Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.

Related Stories
USDA Meteorologist Brad Rippey says a cold front will keep smoke moving east and hopefully clear some smoke sitting over the north-central United States.
Thousands of pork producers from around the globe gathered in Des Moines, Iowa, this week for the World Pork Expo to showcase the latest production innovations and learn about market trends in the industry.
“I’ll say first and foremost, we need to make sure that the crop insurance system is not conflicting with these good farming practices.”